We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+1.43%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.8B
AUM Growth
-$261M
Cap. Flow
-$202M
Cap. Flow %
-1.87%
Top 10 Hldgs %
9.55%
Holding
1,226
New
73
Increased
457
Reduced
388
Closed
76

Top Buys

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$33.4M
2
MLAB icon
Mesa Laboratories
MLAB
+$27.4M
3
TNC icon
Tennant Co
TNC
+$19.8M
4
KWR icon
Quaker Houghton
KWR
+$18.2M
5
HLI icon
Houlihan Lokey
HLI
+$17.9M

Sector Composition

Rank Sector Weight
1 Industrials 28.27%
2 Technology 17.79%
3 Financials 14.2%
4 Consumer Discretionary 12.75%
5 Materials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSPN icon
1001
OneSpan
OSPN
$657M
$81K ﹤0.01%
5,600
VGR
1002
DELISTED
Vector Group Ltd.
VGR
$80K ﹤0.01%
9,481
+1,883
+25% +$14.4K
FTR
1003
DELISTED
Frontier Communications Corp.
FTR
$80K ﹤0.01%
92,436
+54,401
+143% +$61.2K
BTU icon
1004
Peabody Energy
BTU
$3.25B
$79K ﹤0.01%
5,361
+2,624
+96% +$51.1K
WCC
1005
WESCO International
WCC
$16.3B
$79K ﹤0.01%
1,648
+599
+57% +$28.2K
ENT
1006
DELISTED
Global Eagle Entertainment Inc.
ENT
$79K ﹤0.01%
4,400
HOMB icon
1007
Home BancShares
HOMB
$6.04B
$78K ﹤0.01%
4,138
+1,464
+55% +$27.4K
OHAI
1008
DELISTED
OHA Investment Corporation
OHAI
$78K ﹤0.01%
59,761
CATY icon
1009
Cathay General Bancorp
CATY
$4.17B
$77K ﹤0.01%
2,214
+814
+58% +$28.4K
URBN icon
1010
Urban Outfitters
URBN
$6.5B
$77K ﹤0.01%
2,750
+791
+40% +$18.4K
KL
1011
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$77K ﹤0.01%
1,720
-1,000
-37% -$45.7K
MD icon
1012
Pediatrix Medical
MD
$2.17B
$76K ﹤0.01%
+3,377
New +$77K
AR icon
1013
Antero Resources
AR
$11.9B
$75K ﹤0.01%
24,677
+15,084
+157% +$61.5K
CFMS
1014
DELISTED
Conformis, Inc. Common Stock
CFMS
$74K ﹤0.01%
1,592
+835
+110% +$50.2K
DLX icon
1015
Deluxe
DLX
$1.08B
$73K ﹤0.01%
1,491
-646
-30% -$28.8K
ACOR
1016
DELISTED
Acorda Therapeutics
ACOR
$73K ﹤0.01%
212
+11
+5% +$5.98K
TCF
1017
DELISTED
TCF Financial Corporation Common Stock
TCF
$73K ﹤0.01%
1,920
+633
+49% +$25.2K
MIK
1018
DELISTED
Michaels Stores, Inc
MIK
$70K ﹤0.01%
7,143
+1,736
+32% +$13K
UFPI icon
1019
UFP Industries
UFPI
$4.55B
$69K ﹤0.01%
+1,733
New +$67.4K
EAT icon
1020
Brinker International
EAT
$8.5B
$68K ﹤0.01%
1,601
-661
-29% -$26.5K
AMCX icon
1021
AMC Global Media
AMCX
$503M
$67K ﹤0.01%
1,364
+559
+69% +$28.8K
NCMI icon
1022
National CineMedia
NCMI
$228M
$67K ﹤0.01%
812
+138
+20% +$10.3K
NWLI
1023
DELISTED
National Western Life Group, Inc. Class A
NWLI
$67K ﹤0.01%
251
-6,994
-97% -$1.84M
SBH icon
1024
Sally Beauty Holdings
SBH
$1.47B
$66K ﹤0.01%
4,412
+1,632
+59% +$21.3K
BHE icon
1025
Benchmark Electronics
BHE
$2.61B
$65K ﹤0.01%
2,222
-216,318
-99% -$5.78M

Similar funds

Royce & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Royce & Associates held 1,226 positions worth $10.8B, down 2.4% from $11.1B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q3 2019 filing shows 73 new, 457 increased, 388 reduced and 76 closed positions. Its largest new stake was Upbound Group: 521,616 shares worth $13.5M. The largest sale was John B. Sanfilippo & Son, an estimated $73.8M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 29% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2019 buy was Upbound Group: 521,616 shares worth $13.5M.
  • Royce & Associates added most to Virtu Financial in Q3 2019, an estimated $33.4M increase.
  • Royce & Associates's biggest Q3 2019 reduction was John B. Sanfilippo & Son, cutting an estimated $73.8M.
  • Royce & Associates fully exited Cambrex Corporation in Q3 2019, selling an estimated $14.7M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $10.8B portfolio in Q3 2019.
  • Royce & Associates opened 73 new positions and closed 76 in Q3 2019.
  • Royce & Associates's portfolio value fell 2.4% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q3 2019, filed 13 Nov 2019.